This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
Mayo Clinic, discusses ascites, encephalopathy, gastrointestinal bleeding, dysphagia, abdominal discomfort, and Crohn's disease.
Dr. Amy Oxentenko, Assistant Professor of Medicine at Mayo Clinic, discusses "Clinical Pearls in Gastroenterology," including ascites, encephalopathy, gastrointestinal bleeding, dysphagia, abdominal discomfort, and Crohn's disease.
No comments:
Post a Comment